Israel Vega
Roundtable
Israel Vega
Clinical Operations Manager
PRA Health Sciences

Mexico performs a very small number of Phase I clinical trials since Mexican regulation forbids paying patients for their participation in clinical trials, something that does not happen in other countries such as the US, England or some countries in Asia. Phase I trials are performed with healthy patients who are sometimes only motivated to participate in the trials due to the economic benefits, but as these are unavailable in Mexico there is little interest from the general public to participate. Phase II to IV studies involve sick patients throughout several stages of the disease who are willing to participate in the trials as it provides a potential cure for their diseases.

Every year, Mexico increases its capabilities for clinical trials. Although the country is strong in Phase II and III studies
Héctor Avila
View from the Top
Hector Ávila
Director General
Cecyc Pharma
Cecyc Pharma performs clinical research in seven countries: Mexico, Chile, Venezuela, Colombia, Spain, Dominican Republic and South Africa
There are 122 authorized testing laboratories, 62 units of interchangeability and biocomparability and 26 verification units
Analysis
All drugs sold in Mexico must be tested by COFEPRIS, which led to a backlog that has since been solved by the creation of authorized third parties.
Héctor Ávila
View from the Top
Héctor Ávila
Director General
Cecyc Pharma
Cecyc Pharma is an authorized third party located in Mexico City.
Subscribe to Cecyc Pharma